title: Experts disagree over NICE's approach for assessing drugs.
authors.forename: Richard
authors.initials: R
authors.lastname: Hoey
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy*; D002800:Cholinesterase Inhibitors / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D015276:Health Care Rationing / Q000331:legislation & jurisprudence*; D006801:Humans; D018697:Nootropic Agents / Q000191:economics* / Q000627:therapeutic use; D019057:Quality-Adjusted Life Years; D006113:United Kingdom
chemical_list: D002800:Cholinesterase Inhibitors; D018697:Nootropic Agents